Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Comprehensive Myopathy Panel Invitae United States | 143 | 70 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Invitae United States | 353 | 208 |
|
Invitae Cardiomyopathy Comprehensive Panel Invitae United States | 198 | 82 |
|
Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel Invitae United States | 239 | 100 |
|
Invitae Hypertrophic Cardiomyopathy Panel Invitae United States | 69 | 30 |
|
X-chromosome High Resolution microarray analysis Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 240 | 171 |
|
FHL1-Myopathies via the FHL1 Gene PreventionGenetics, part of Exact Sciences United States | 4 | 1 |
|
Arthrogryposis panel. NGS panel of 69 genes. Genologica Medica Spain | 135 | 69 |
|
Emery-Dreifuss muscular dystrophy panel. 6-gene NGS panel. Genologica Medica Spain | 27 | 6 |
|
FHL1 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 5 | 1 |
|
Neuromuscular Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 138 | 62 |
|
Fulgent Genetics United States | 186 | 61 |
|
Comprehensive Cardiomyopathy NGS Panel Fulgent Genetics United States | 450 | 128 |
|
Fulgent Genetics United States | 175 | 60 |
|
Muscle Polyneuropathies , Panel Massive Sequencing (NGS) 111 Genes Reference Laboratory Genetics Spain | 159 | 111 |
|
Congenital Myopathy and Distal Myopathy NGS panel Asper Biogene Asper Biogene LLC Estonia | 78 | 41 |
|
Neuromuscular Disorders NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 233 | 144 |
|
Comprehensive Cardiac NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 174 | 108 |
|
Congenital Muscular Dystrophy Advanced Sequencing Evaluation Athena Diagnostics United States | 37 | 23 |
|
Muscular Dystrophy Advanced Evaluation Athena Diagnostics United States | 53 | 33 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.